Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Rosenberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The EMBO Journal|March 19, 2005
Bacterial DNA segregation dynamics mediated by the polymerizing protein ParFDaniela Barillà, Mark F Rosenberg, Ulf Nobbmann, et al.
Current Drug Metabolism|September 4, 2010
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)Zhanglin Ni, Zsolt Bikadi, Mark F Rosenberg, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
CFTR three-dimensional structureRobert C Ford, James Birtley, Mark F Rosenberg, et al.
American Journal of Physiology. Cell Physiology|August 27, 2010
Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transportZhanglin Ni, Zsolt Bikadi, Xiaokun Cai, et al.
The Journal of Biological Chemistry|October 16, 2004
Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound stateMark F Rosenberg, Richard Callaghan, Szabolcs Modok, et al.
The Journal of Biological Chemistry|December 27, 2002
Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide bindingMark F Rosenberg, Alhaji Bukar Kamis, Richard Callaghan, et al.
Biochemistry|August 23, 2011
Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificityZhanglin Ni, Zsolt Bikadi, Diana L Shuster, et al.
The Journal of Biological Chemistry|July 13, 2004
Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR)Mark F Rosenberg, Alhaji Bukar Kamis, Luba A Aleksandrov, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2010
Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transportXiaokun Cai, Zsolt Bikadi, Zhanglin Ni, et al.
Structure (London, England : 1993)|April 20, 2010
The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantroneMark F Rosenberg, Zsolt Bikadi, Janice Chan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The EMBO Journal|March 19, 2005
Bacterial DNA segregation dynamics mediated by the polymerizing protein ParFDaniela Barillà, Mark F Rosenberg, Ulf Nobbmann, et al.
Current Drug Metabolism|September 4, 2010
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)Zhanglin Ni, Zsolt Bikadi, Mark F Rosenberg, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
CFTR three-dimensional structureRobert C Ford, James Birtley, Mark F Rosenberg, et al.
American Journal of Physiology. Cell Physiology|August 27, 2010
Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transportZhanglin Ni, Zsolt Bikadi, Xiaokun Cai, et al.
The Journal of Biological Chemistry|October 16, 2004
Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound stateMark F Rosenberg, Richard Callaghan, Szabolcs Modok, et al.
The Journal of Biological Chemistry|December 27, 2002
Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide bindingMark F Rosenberg, Alhaji Bukar Kamis, Richard Callaghan, et al.
Biochemistry|August 23, 2011
Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificityZhanglin Ni, Zsolt Bikadi, Diana L Shuster, et al.
The Journal of Biological Chemistry|July 13, 2004
Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR)Mark F Rosenberg, Alhaji Bukar Kamis, Luba A Aleksandrov, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2010
Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transportXiaokun Cai, Zsolt Bikadi, Zhanglin Ni, et al.
Structure (London, England : 1993)|April 20, 2010
The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantroneMark F Rosenberg, Zsolt Bikadi, Janice Chan, et al.
Pageof 2